Arama Sonuçları - Michael Unterhalt

Sonuçları Daraltın
  1. 1
    The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome

    The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-lin... Yazar: Christian Buske, Eva Hoster, Martin Dreyling, Joerg Hasford, Michael Unterhalt, Wolfgang Hiddemann

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Moderate Increase of Secondary Hematologic Malignancies After Myeloablative Radiochemotherapy and Autologous Stem-Cell Transplantation in Patients With Indolent Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group

    Moderate Increase of Secondary Hematologic Malignancies After Myeloablative Radiochemotherapy and Autologous Stem-Cell Transplantation in Patients With Indolent Lymphoma: Results o... Yazar: Georg Lenz, Martin Dreyling, Eva Schiegnitz, Torsten Haferlach, Joerg Hasford, Michael Unterhalt, Wolfgang Hiddemann

    Baskı/Yayın Bilgisi 2004
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

    Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the... Yazar: Olaf Determann, Eva Hoster, German Ott, Heinz Wolfram Bernd, Christoph Loddenkemper, Martin L. Hansmann, T. Barth, Michael Unterhalt, Wolfgang Hiddemann, Martin Dreyling, Wolfram Klapper

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations

    Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial sta... Yazar: Sebastian Böttcher, Matthias Ritgen, Sebastian Buske, Stefan Gesk, W. Klapper, Eva Hoster, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling, Reiner Siebert, Michael Kneba, Christiane Pott

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group

    Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study G... Yazar: Vindi Jurinović, Bernd Metzner, Michael Pfreundschuh, Norbert Schmitz, Hannes Wandt, Ulrich Keller, Peter Dreger, Martin Dreyling, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Oliver Weigert

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma

    Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma Yazar: A. Z. S. Rohatiner, Walter M. Gregory, B. A. Peterson, Borden Ec, Philippe Solal‐Céligny, Anton Hagenbeek, R I Fisher, Michael Unterhalt, R. Arranz, Teodoro Chisesi, Agustín Avilés, Tim Lister

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma

    Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma Yazar: Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, B. Gahn, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)

    Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, an... Yazar: Roswitha Forstpointner, Michael Unterhalt, Martin Dreyling, Hans-Peter Böck, Roland Repp, H. Wandt, Christiane Pott, John F. Seymour, Bernd Metzner, Annette Hänel, Thomas Lehmann, Frank Hartmann, Hermann Einsele, Wolfgang Hiddemann

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

    Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression) Yazar: Gabriel Scheubeck, Linmiao Jiang, Olivier Hermine, Hanneke C. Kluin‐Nelemans, Christian Schmidt, Michael Unterhalt, Andreas Rosenwald, Wolfram Klapper, Andrea Evangelista, Marco Ladetto, Mats Jerkeman, Simone Ferrero, Martin Dreyling, Eva Hoster

    Baskı/Yayın Bilgisi 2023
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemotherapy

    Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential Efficacy of Chemo... Yazar: Vindi Jurinović, Verena Passerini, Mikkel Z. Oestergaard, Andrea Knapp, Kirsten Mundt, Shamzah Araf, Julia Richter, Jude Fitzgibbon, Wolfram Klapper, Robert Marcus, Andrew Davies, Michael Herold, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Oliver Weigert

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

    Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma Yazar: A. Herrmann, Eva Hoster, Thomas Zwingers, Günter Brittinger, M. Engelhard, P. Meusers, Marcel Reiser, Roswitha Forstpointner, Bernd Metzner, Norma Peter, Bernhard Wörmann, Lorenz Trümper, Michael Pfreundschuh, Hermann Einsele, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

    Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Ou... Yazar: Georg Lenz, Martin Dreyling, Eva Hoster, Bernhard Wörmann, Ulrich Dührsen, Bernd Metzner, Hartmut Eimermacher, Andreas Neubauer, Hannes Wandt, Hjalmar B. Steinhauer, Sonja Martin, E. Heidemann, Ali Aldaoud, Reza Parwaresch, Joerg Hasford, Michael Unterhalt, Wolfgang Hiddemann

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL

    Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL Yazar: Karoline Koch, Eva Hoster, Marita Ziepert, Michael Unterhalt, German Ott, Andreas Rosenwald, Martin L. Hansmann, Wollnik Bernd, Harald Stein, Viola Pöschel, Martin Dreyling, Lorenz Trümper, Markus Löffler, Norbert Schmitz, Wolfgang Hiddemann, Michael Pfreundschuh, W. Klapper

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

    High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma Yazar: Marie‐Hélène Delfau‐Larue, Wolfram Klapper, Françoise Berger, Fabrice Jardin, Josette Brière, Gilles Salles, Olivier Casasnovas, Pierre Feugier, Corinne Haïoun, Vincent Ribrag, Catherine Thiéblemont, Michael Unterhalt, Martin Dreyling, Elizabeth Macintyre, Christiane Pott, Olivier Hermine, Eva Hoster

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Tumor Sclerosis but Not Cell Proliferation or Malignancy Grade Is a Prognostic Marker in Advanced-Stage Follicular Lymphoma: The German Low Grade Lymphoma Study Group

    Tumor Sclerosis but Not Cell Proliferation or Malignancy Grade Is a Prognostic Marker in Advanced-Stage Follicular Lymphoma: The German Low Grade Lymphoma Study Group Yazar: Wolfram Klapper, Eva Hoster, Lars Rölver, Carsten Schrader, Dirk Janssen, Markus Tiemann, Heinz‐Wolfram Bernd, Olaf Determann, Martin‐Leo Hansmann, Peter Möller, Alfred C. Feller, Harald Stein, Hans‐Heinrich Wacker, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann, German Ott

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network

    Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network Yazar: Eva Hoster, Wolfram Klapper, Olivier Hermine, Hanneke C. Kluin‐Nelemans, Jan Walewski, Achiel Van Hoof, Marek Trněný, Christian H. Geisler, Francesco Di Raimondo, Michał Szymczyk, Stephan Stilgenbauer, Catherine Thiéblemont, Michael Hallek, Roswitha Forstpointner, Christiane Pott, Vincent Ribrag, Jeanette K. Doorduijn, Wolfgang Hiddemann, Martin Dreyling, Michael Unterhalt

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

    Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma... Yazar: Martin Dreyling, Jeanette K. Doorduijn, Eva Giné, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trněný, Vibeke Vergote, Melania Celli, Ofer Shpilberg, María Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Christiane Pott, Wolfram Klapper, Döndü Gözel, Christian Schmidt, Michael Unterhalt, Marco Ladetto, Eva Hoster

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

    Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy Yazar: Vindi Jurinović, Robert Kridel, Annette M. Staiger, Monika Szczepanowski, Heike Horn, Martin Dreyling, Andreas Rosenwald, German Ott, Wolfram Klapper, Andrew D. Zelenetz, Paul M. Barr, Jonathan W. Friedberg, Stephen M. Ansell, Laurie H. Sehn, Joseph M. Connors, Randy D. Gascoyne, Wolfgang Hiddemann, Michael Unterhalt, David M. Weinstock, Oliver Weigert

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial

    Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial Yazar: Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Christian H. Geisler, Marek Trněný, Stephan Stilgenbauer, Florian Kaiser, Jeanette K. Doorduijn, Gilles Salles, Michał Szymczyk, Hervé Tilly, Lothar Kanz, Christian Schmidt, Pierre Feugier, Catherine Thiéblemont, Josée M. Zijlstra, Vincent Ribrag, Wolfram Klapper, Christiane Pott, Michael Unterhalt, Martin Dreyling

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial

    Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multice... Yazar: Anna‐Katharina Zoellner, Michael Unterhalt, Stephan Stilgenbauer, Kai Hübel, Catherine Thiéblemont, Bernd Metzner, Max S. Topp, Lorenz Truemper, Christian Schmidt, Kamal Bouabdallah, Jürgen Krauter, Georg Lenz, Jan Dürig, Vibeke Vergote, Kerstin Schäfer‐Eckart, Marc André, Hanneke C. Kluin‐Nelemans, Achiel Van Hoof, Wolfram Klapper, Wolfgang Hiddemann, Martin Dreyling, Eva Hoster

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: